CME questions for March 2005

CME questions for March 2005

FERTILITY AND STERILITY ® CONTINUING MEDICAL EDUCATION QUESTIONS To obtain the 15 Category I CME credits, the entire examination of lessons from Volum...

39KB Sizes 1 Downloads 44 Views

FERTILITY AND STERILITY ® CONTINUING MEDICAL EDUCATION QUESTIONS To obtain the 15 Category I CME credits, the entire examination of lessons from Volume 83 of Fertility and Sterility® must be taken. The answer sheet will be available in the June 2005 issue and will be graded. A 70% passing score must be achieved and documentation will be mailed with the corrected examination to the participant. March 2005 Ferrero et al. 83:573–9 (Lesson 8)

Jain et al. 83:649 –58 (Lesson 10)

Objective: To characterize sexual function among women with endometriosis and deep dyspareunia

Objective: To determine the demand and preferences of infertility patients for sex selection

1. Which of the following diagnoses is most unlikely to be a cause for deep dyspareunia? a) pelvic inflammatory disease b) pelvic adhesions c) pelvic congestion d) ulcerative colitis e) interstitial cystitis

1. Which of the following methods for sex selection is acceptable to the ASRM Ethics Committee for nonmedical indications? a) sperm separation b) preimplantation genetic diagnosis c) chorionic villus biopsy d) ultrasound e) amniocentesis

2. Patients with uterosacral endometriosis are more likely to have which of the following? a) less interest in sexual intercourse b) less satisfaction with their partner c) more frequent sexual intercourse each week d) more difficulty relaxing during sexual intercourse e) more interruptions of sexual intercourse by pain

2. Which of the following characteristics describes the person who is most likely to have a significant preference for sex selection? a) older b) single c) Caucasian d) college educated e) wealthier Noble et al. 83:684 –90 (Lesson 11)

Palomino et al. 83:587–93 (Lesson 9) Objective: To assess the effect of clomiphene citrate on endometrium during the window of implantation

Objective: To evaluate treatments for antiphospholipid antibodies associated with recurrent pregnancy loss

1. Which of the following molecules is not linked by Palomino et al. to implantation? a) leukemia inhibitory factor b) platelet-activating inhibitory factor c) epidermal growth factor d) integrins e) progesterone receptor

1. Which therapy for antiphospholipid antibodies associated with recurrent pregnancy loss has provided the highest treatment success rates with a low occurrence of side effects? a) heparin alone b) aspirin alone c) heparin ⫹ low-dose aspirin d) prednisone e) intravenous gamma globulin

2. Which of the following molecular patterns is found in women who have an “out of phase” implantation window? a) epithelial progesterone receptor up-regulation b) high ␤3 integrin subunit expression c) high ␣1 integrin expression d) high plasma progesterone level e) high plasma estrogen level

2. What is the major limitation on the results observed in this study? a) the absence of a placebo control group b) the two-center study design c) the differences in population demographics d) the small number of recruited subjects e) the patient ethnic mix does not reflect the population in the United States

820

Fertility and Sterility姞 Vol. 83, No. 3, March 2005 Copyright ©2005 American Society for Reproductive Medicine, Published by Elsevier Inc.